Isabelle Brenot-Rossi - Dept Nucl Med, Inst Paoli Calmettes

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 43 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Predictive Factors for Persistent Thrombocytopenia after Peptide Receptor Radioligand Therapy in Enteropancreatic Neuroendocrine Tumors

Romain Ferrara, Christophe Zemmour, Thibaut Reichert, Daniel Ouk,Patricia Niccoli, Jemima Maniry-Quellier,Isabelle Brenot-Rossi, Nathalie Charrier, Sandrine Oziel-Taieb

Frontiers in endocrinology (2025): 1568243-1568243

Cited0Views0WOSBibtex

Prognostic Value of FDG PET Metabolic Parameters Before and after 42 Gy of Radiochemotherapy in Patients with Inoperable Stage III Nonsmall Cell Lung Cancer

Pierre Vera,Philippe Giraud, Sébastien Hapdey,Pierrick Gouel, Orianne Jan, Paul Le Roux,Alexandra Langlais, Emilie Lévêque,Florence Le Tinier, Anaïs Olivier,Etienne Martin, Alina Berriolo-Riedinger,Nicolas Pourel, Jean Marc Broglia,Pierre Boisselier, Sophie Guillemard,Naji Salem,Isabelle Brenot-Rossi,Camilo Garcia, Céline Berthold,Etienne Giroux-Leprieur, Damien Moreau,Sophie Guillerm, Khadija Benali,Laurent Tessonnier,Clarisse Audigier-Valette,Delphine Lerouge,Elske Quak,Carole Massabeau, Frédéric Courbon, Maxime Loo,Anne Larrouy, Nadia Ghazzar, Philippe Chaumet-Riffaud, Elodie Amour, Gérard Zalcman,Romain Modzelewski,Sébastien Thureau

Journal of nuclear medicine official publication, Society of Nuclear Medicineno. 4 (2025): 516-524

Cited0Views0WOSBibtex

Adaptive Radiotherapy (up to 74 Gy) or Standard Radiotherapy (66 Gy) for Patients with Stage III Non-Small- Cell Lung Cancer, According to [18F]FDG-PET 18 F]FDG-PET Tumour Residual Uptake at 42 Gy (RTEP7-IFCT-1402): a Multicentre, Randomised, Controlled Phase 2 Trial

LANCET ONCOLOGYno. 9 (2024): 1176-1187

Cited0Views0Bibtex

Adaptive Radiotherapy (up to 74 Gy) or Standard Radiotherapy (66 Gy) for Patients with Stage III Non-Small-cell Lung Cancer, According to [18F]FDG-PET Tumour Residual Uptake at 42 Gy (RTEP7–IFCT-1402): a Multicentre, Randomised, Controlled Phase 2 Trial

Pierre Vera,Sébastien Thureau,Florence Le Tinier,Philippe Chaumet-Riffaud,Sébastien Hapdey,Hélène Kolesnikov-Gauthier,Etienne Martin,Alina Berriolo-Riedinger,Nicolas Pourel, Jean Marc Broglia, Pierre Boissellier,Sophie Guillemard,Naji Salem,Isabelle Brenot-Rossi,Cécile Le Péchoux, Céline Berthold,Etienne Giroux-Leprieur,Damien Moreau,Sophie Guillerm,Khadija Benali

The Lancet Oncology (2024)

Cited0Views0WOSBibtex

Radioisotope-guided Lymphadenectomy for Pelvic Lymph Node Staging in Patients with Intermediate- and High-risk Prostate Cancer (the Prospective SENTINELLE Study)

Francois Lannes,Michael Baboudjian,Alain Ruffion,Mathieu Rouy,Francesco Giammarile,Thierry Rousseau,Francoise Kraeber-Bodere,Caroline Rousseau,Daniela Rusu,Mathilde Colombie,Isabelle Brenot-Rossi,Dominique Rossi,Nicolas Mottet,Cyrille Bastide

JOURNAL OF UROLOGY（2023）

Cited8Views0WOSBibtex

PET-MRI for Evaluation of Response to Radiochemotherapy in Patients with Locally Advanced Cervical Cancer

Ariane Weyl,Charlotte Chollet,Erwan Gabiache,Valerie Cances-Lauwers,Franklin Gallo,Alejandra Martinez,Frederic Courbon,Pierre Leguevaque,Isabelle Brenot Rossi,Aurelie Jalaguier,Eric Lambaudie,Elodie Chantalat,Stephanie Motton

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER（2023）

Cited5Views0WOSBibtex

Allogeneic Transplant As a Curative Option for Relapsed/Refractory Large B-Cell Lymphoma in the Era of CAR T-Cell Therapy: A Monocentric Retrospective Study

Pauline Roche,Gabriel Brisou,Sabine Furst,Robin Noel,Catalina Montes De Oca,Aude Collignon,Luca Inchiappa,Jean Marc Schiano De Colella,Isabelle Brenot Rossi, Thibaut Reichert,Sophie Thevenet,Bechara Mfarrej,Boris Calmels,Didier Blaise,Christian Chabannon,Raynier Devillier

Blood（2022）

Cited0Views0Bibtex

Brachytherapy for Oligometastatic Prostate Cancer to the Penis

Nicolas Martz,Nicolas Benziane-Ouaritini,Mathieu Gautier,Isabelle Brenot-Rossi,Lucile Montagne,Naji Salem,Yohan Bodokh,Jean-Michel Hannoun-Levi

Journal of Contemporary Brachytherapy（2021）

Cited2Views0WOSBibtex

Prognostic Risk Classification for Biochemical Relapse-Free Survival in Oligometastatic Recurrent Prostate Cancer Determined by Choline PET

Gwenaelle Gravis,Aurelie Autret,Morgane Guibert-Broudic, Thomas Duberge,Christophe Zemmour, Patricia Carrier,Naji Salem,Delphine Badinand,Lysian Cartier,Emmanuel Gross,Jochen Walz,Geraldine Pignot,Isabelle Brenot-Rossi

Clinical Genitourinary Cancer（2021）

Cited1Views0WOSBibtex

The Management of a Comprehensive Cancer Center During the First Six Months of the COVID-19 Pandemic in the South of France: Lessons from the Paoli-Calmettes Institute’s Experience

Didier Blaise,Pierre Berger,Djamel Mokart,Jacques Camerlo,Emmanuelle Fougereau,Marc Giovannini,Gilles Houvenaeghel,Olivier Turrini,Christian Chabannon,Gilles Piana,Isabelle Brenot-Rossi,Agnès Tallet,Anthony Gonçalves,Aude Charbonnier,Norbert Vey, Sabrina Grossi,Patrice Viens

Clinical Hematology International（2021）

Cited3Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn